Sort
11,323 grants matching “glioblastoma”
Glioblastoma Phenotype Modulation Through miRNA Control of Wnt Signaling
$354,908Shi-Yuan Cheng · Northwestern University At Chicago · R01 · FY2017 · NS
Enhanced synthetic luciferin substrates for firefly luciferase
$354,776Stephen C. Miller · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · EB
Role of RBBP4/p300 Complex in Recovery from therapy induced DNA damage in glioblastoma
$354,592Gaspar Julius Kitange · University Of Minnesota · R01 · FY2022 · CA
Role of RBBP4/p300 Complex in Recovery from therapy induced DNA damage in glioblastoma
$354,592Gaspar Julius Kitange · University Of Minnesota · R01 · FY2023 · CA
GENETICALLY ENGINEERED VIRUSES FOR BRAIN TUMOR THERAPY
$354,564Massachusetts General Hospital · R01 · FY2001 · NS
Convertible MRI Contrast Ignaling Delivery and Release of Anti-glioma Nano-drug
$354,563Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2017 · CA
Convertible MRI Contrast Ignaling Delivery and Release of Anti-glioma Nano-drug
$354,563Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2016 · CA
Convertible MRI Contrast Ignaling Delivery and Release of Anti-glioma Nano-drug
$354,563Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2018 · CA
Targeting Mutant IDH1 for a Novel Synthetic Lethal Interaction in Malignant Gliomas
$354,375Markus D Siegelin · Columbia University Health Sciences · R01 · FY2021 · NS
Targeting Mutant IDH1 for a Novel Synthetic Lethal Interaction in Malignant Gliomas
$354,375Markus D Siegelin · Columbia University Health Sciences · R01 · FY2022 · NS
Targeting Mutant IDH1 for a Novel Synthetic Lethal Interaction in Malignant Gliomas
$354,375Markus D Siegelin · Columbia University Health Sciences · R01 · FY2019 · NS
Targeting Mutant IDH1 for a Novel Synthetic Lethal Interaction in Malignant Gliomas
$354,375Markus D Siegelin · Columbia University Health Sciences · R01 · FY2020 · NS
Developing diagnostic and therapeutic stem cells for cancer therapy
$354,365Khalid A Shah · Massachusetts General Hospital · R01 · FY2011 · CA
Developing diagnostic and therapeutic stem cells for cancer therapy
$354,298Khalid A Shah · Massachusetts General Hospital · R01 · FY2012 · CA
Time-reversal acoustic device for enhanced drug delivery for brain gliomas
$354,265Armen Sarvazyan · Artann Laboratories, Inc. · R43 · FY2010 · NS
Detecting invading glioma cells through in vivo molecular imaging of the cell sur
$354,264Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2013 · NS
The role and mechanism of necrosis in glioblastoma
$354,108Wei Li · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · NS
Targeting Refractory EGFR-Driven Tumors By Induction Of Dominant-Negative EGFR Splicing Variants
$354,099Luca Cartegni · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Novel multipronged Immunovirotherapy Approach for GBM Treatment
$354,017Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2021 · CA
Targeting Refractory EGFR-Driven Tumors By Induction Of Dominant-Negative EGFR Splicing Variants
$354,012Luca Cartegni · Rutgers, The State Univ Of N.J. · R01 · FY2022 · CA
Effectively Targeting Notch in Hypoxic Brain Tumor Cells
$353,991Charles George Eberhart · Johns Hopkins University · R01 · FY2015 · NS
Effectively Targeting Notch in Hypoxic Brain Tumor Cells
$353,983Charles George Eberhart · Johns Hopkins University · R01 · FY2016 · NS
Optimizing MRI for Radiation Therapy Treatment Planning
$353,890James Michael Balter · University Of Michigan At Ann Arbor · R01 · FY2018 · EB
Differential response of glioblastomas to microtubule targeting agents
$353,812Nephi Stella · University Of Washington · R01 · FY2022 · CA
Project 3 - Targeting CDK4/6 to modulate immunogenicity in gliomas (Wen/Zhao)
$353,666Jean Zhao · Brigham And Women'S Hospital · P50 · FY2021 · CA